February 1970

Psychological Effects of Tetrahydrocannabinol

Author Affiliations

Chevy Chase, Md
From the Special Studies Section, Psychopharmacology Research Branch, National Institute of Mental Health, Chevy Chase, Md. Dr. Olsson is currently with the Medical Office, Supreme Bench of Baltimore, and Dr. Salzman is currently with the Massachusetts Mental Health Center, and Harvard Medical School, Boston. Drs. Waskow and Katz are currently with the Clinical Research Branch, NIMH, Chevy Chase, Md.

Arch Gen Psychiatry. 1970;22(2):97-107. doi:10.1001/archpsyc.1970.01740260001001

THE MORE widespread use of marihuana and marihuana-like drugs in the general population and the controversy about their possible harmful, as well as beneficial, effects have led to an increased interest in studying these compounds during the last few years. At the same time, the identification of l-Δ1-3,4 trans-tetrahydrocannabinol (THC) as a constituent of marihuana and its synthesis by Gaoni and Mechoulam1,2 have made possible the systematic study of this substance, which is presumed to be the most active element in marihuana (l-Δ1 is also referred to as l-Δ9; l-Δ1 follows terpene nomenclature, which was used by Mechoulam and Gaoni, whereas l-Δ9 follows standard chemical abstracts nomenclature).

The major aim of the present study is the delineation of some of the psychological effects of THC. This paper will deal primarily with the systematic measurement of

First Page Preview View Large
First page PDF preview
First page PDF preview